Ireland
--:--IST
Latest
Clinical Trials in Canada / NCT06683209
Starting soon Not applicable

Optimizing Patient's Comfort During Scleral Indentation

NCT06683209 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2027-07-01
Last updated
2026-08-17

Condition(s) studied

Pain

Investigational drug(s) / intervention(s)

Schocket scleral depressorJosephberg-BesserCotton tip applicator

Schocket scleral depressor: Use of this instrument to examine one eye

Josephberg-Besser: Use of this instrument to examine one eye

Cotton tip applicator: Use of this instrument to examine one eye

Study summary

The scleral depression exam is an important routine technique for evaluating the retinal periphery for various reasons. During this examination, an instrument is used to bring the anterior part of the retina into the physician's field of view. The downside of this technique is the discomfort it may cause the patient. Different instruments can be used to depress the sclera.

The objective of this research is to compare three commonly used scleral depressors based on their performance for the ophthalmologist and the discomfort they subjectively induce in patients.

Patients will be randomly allocated to one of three examination groups:

Group A: One eye examined with the Schocket scleral depressor, the other eye with the Josephberg-Besser scleral depressor.

Group B: One eye examined with the Schocket scleral depressor, the other eye with the cotton-tip applicator.

Group C: One eye examined with the cotton-tip applicator, the other eye with the Josephberg-Besser scleral depressor.

Eligibility

Sex
ALL
Min age
18 Years
Max age
100 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Symptomatic posterior vitreous detachment with or without vitreoretinal pathology Exclusion Criteria: * Monocular status. * Media opacity which precludes view of the peripheral retina. * Inadequate examination (cooperation with examination, inability to achieve all directions of gaze). * Underlying oculodynia (recent surgery, intraocular inflammation, abnormal intraocular pressure, ocular dysesthesia syndromes (ocular, adnexal or orbital). * History of pain-sensitizing conditions or current analgesic use. * Previous scleral indented examination poorly tolerated.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Alberta Retina Consultant Edmonton Alberta
Sunnybrook Hospital Toronto Ontario

More University of Alberta trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06683209 on ClinicalTrials.gov ↗ ← All trials in Canada